effect of probiotic in cirrhosis patients

Comparative study of improvement quality of life before and after lactulose and probiotic in cirrhotic patient

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190306042944N1

Enrollment

Registered

2019-04-14

Start date

2017-11-22

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis. Fibrosis and cirrhosis of liver

Interventions

Intervention 1: Intervention group: Lactulose plus probiotics. Intervention 2: Intervention group: Lactulose.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: cirrhosis with any reasons Age above 18

Exclusion criteria

Exclusion criteria: Chronic physical or sychiatric illness Encephalopathy Active infection Addiction Intake immunosuppressive drugs Patient Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Quality of life in cirrhosis patients. Timepoint: At the beginning of the study and 3 months later (end of the study). Method of measurement: According to the quality of life questionnaire for chronic liver patients (CLDQ).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDamoon Dehnavi

Ahvaz University of Medical Sciences

dr.damoon@yahoo.com+98 61 3321 4578

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026